Bristol-Myers Squibb Company (BMY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
12-2013 | 12-2012 | 12-2011 | 12-2010 | 12-2009 | |
Cash Flows From Operating Activities | |||||
Net Income | 2,580,000 | 2,501,000 | 5,260,000 | 4,513,000 | 11,862,000 |
Depreciation Amortization | 763,000 | 973,000 | 628,000 | 607,000 | 707,000 |
Income taxes - deferred | -491,000 | -1,230,000 | 415,000 | 422,000 | 163,000 |
Accounts receivable | -504,000 | 648,000 | -220,000 | -270,000 | 227,000 |
Accounts payable and accrued liabilities | N/A | N/A | 593,000 | 315,000 | N/A |
Other Working Capital | 194,000 | -631,000 | 104,000 | -29,000 | 974,000 |
Other Operating Activity | 1,003,000 | 4,680,000 | -1,940,000 | -1,067,000 | -9,868,000 |
Operating Cash Flow | $3,545,000 | $6,941,000 | $4,840,000 | $4,491,000 | $4,065,000 |
Cash Flows From Investing Activities | |||||
Change In Deposits | -44,000 | -3,607,000 | -859,000 | -5,823,000 | -3,489,000 |
PPE Investments | -537,000 | -548,000 | -367,000 | -424,000 | -173,000 |
Net Acquisitions | 9,000 | -7,462,000 | -211,000 | -762,000 | -2,232,000 |
Sale Of Investment | N/A | 4,890,000 | N/A | 3,197,000 | 2,075,000 |
Other Investing Activity | 0 | 0 | 0 | 0 | -561,000 |
Investing Cash Flow | $-572,000 | $-6,727,000 | $-1,437,000 | $-3,812,000 | $-4,380,000 |
Cash Flows From Financing Activities | |||||
Change In Short Term Borrowing | 198,000 | 49,000 | -1,000 | -33,000 | -26,000 |
Debt Issued | 892,000 | 1,950,000 | N/A | 6,000 | 1,683,000 |
Debt Repayment | N/A | -2,108,000 | -78,000 | -936,000 | -212,000 |
Common Stock Issued | 564,000 | 463,000 | 601,000 | 252,000 | 827,000 |
Common Stock Repurchased | -433,000 | -2,403,000 | -1,221,000 | -576,000 | 0 |
Dividend Paid | -2,309,000 | -2,286,000 | -2,254,000 | -2,202,000 | -2,483,000 |
Other Financing Activity | 20,000 | 2,000 | 296,000 | 146,000 | 194,000 |
Financing Cash Flow | $-1,068,000 | $-4,333,000 | $-2,657,000 | $-3,343,000 | $-17,000 |
Exchange Rate Effect | 25,000 | -1,000 | -3,000 | 14,000 | 39,000 |
Beginning Cash Position | 1,656,000 | 5,776,000 | 5,033,000 | 7,683,000 | 7,976,000 |
End Cash Position | 3,586,000 | 1,656,000 | 5,776,000 | 5,033,000 | 7,683,000 |
Net Cash Flow | $1,930,000 | $-4,120,000 | $743,000 | $-2,650,000 | $-293,000 |
Free Cash Flow | |||||
Operating Cash Flow | 3,545,000 | 6,941,000 | 4,840,000 | 4,491,000 | 4,065,000 |
Capital Expenditure | -537,000 | -548,000 | -367,000 | -424,000 | -730,000 |
Free Cash Flow | 3,008,000 | 6,393,000 | 4,473,000 | 4,067,000 | 3,335,000 |